News provided by Designs for Health Jun 17, 2026, 10:17 ET New probiotic and postbiotic blend targets microbiome health, metabolic balance, and healthy body composition through clinically studied ingredients* PALM COAST, Fla., June 17, 2026 /PRNewswire/ -- Designs for Health, the practitioner-recommended and preferred brand for high-quality, research-backed supplements, today announced the launch of Akkermansia Pro GLP-1 Probiotic, a groundbreaking once-daily probiotic and postbiotic formula that combines live Akkermansia muciniphila with the clinically studied BPL1 postbiotic to support the gutmetabolic connection, the body's natural GLP-1 production, and healthy weight management.* As research continues to explore the connection between the gut microbiome and metabolic health, emerging science suggests that specific keystone bacterial strains, those that are foundational to the gut microbiome, may play a vital role in supporting appetite regulation, blood sugar metabolism, gut barrier integrity, and overall metabolic resilience

Mild dizziness that resolves with hydration and time is a common, non-dangerous adjustment symptom
Boosted immunity
Theyre signaling peptides that help skin cells communicate effectively
Compounded semaglutide is prepared for an individual patient by a 503A compounding pharmacy and is not FDA-approved
By way of further example, documentation of supplier due-diligence and other compliance efforts is often critical to blunt accusations of bad faith or recklessness